Literature DB >> 418431

The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.

I Falloon, D C Watt, M Shepherd.   

Abstract

A blind social assessment at home carried out twice during a year's follow-up of 41 patients on continuation therapy, 21 randomly allocated to pimozide tablets and 20 to fluphenazine decanoate injections. Patients on pimozide were significantly more favourably rated on aspects of sociability, use of leisure, warmth of personal relationships, household tasks and child-rearing. The mode of production of this result is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418431     DOI: 10.1017/s0033291700014318

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study.

Authors:  H Biehl; K Maurer; C Schubart; B Krumm; E Jung
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 2.  Continuous versus intermittent neuroleptic therapy in schizophrenia.

Authors:  A G Jolley; S R Hirsch
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

3.  Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.

Authors:  T R Barnes; G Milavic; D A Curson; S D Platt
Journal:  Soc Psychiatry       Date:  1983

4.  The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse.

Authors:  K Vaughan; M Doyle; N McConaghy; A Blaszczynski; A Fox; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

5.  The relationships between depression and remission in first-episode psychosis.

Authors:  Piet Oosthuizen; Robin Emsley; Dana Niehaus; Liezl Koen; Bonga Chiliza
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

6.  Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.

Authors:  A G Jolley; S R Hirsch; A McRink; R Manchanda
Journal:  BMJ       Date:  1989-04-15

7.  Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.

Authors:  A G Jolley; S R Hirsch; E Morrison; A McRink; L Wilson
Journal:  BMJ       Date:  1990-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.